21 May 2009
Hypertension and cardiovascular disease in living kidney donors in Poland – one centre experience
M Bieniasz, A Kwiatkowski, P Domagała, R Kieszek, J Gozdowska, M Durlik, L Pączek, A Deptuła, J Trzebicki, P Pruszczyk, A ChmuraAnn Transplant 2009; 14(1): 50-50 :: ID: 880382
Abstract
Background: Living kidney donation is one of the few instances in medicine in
which a healthy individual undergoes a surgical intervention for the principal
benefit of someone else. The short-term complications of living donation are
infrequent, making it a safe procedure. However, the long-term risk of hypertension and cardiovascular disease remains uncertain. The aim of this study was to evaluate cardiovascular disease and hypertension in living kidney donors.
Material/Methods: A total of 66 living donor open nephrectomies were performed in the Department of General and Transplantation Surgery at the Warsaw Medical University between 1995 and 2005. Physical examination, blood and urine tests, ECG, ambulatory blood pressure measurement, cardiac echography and ophthalmoscopy were performed. Donor mean age was 40.9 years (range 29-60). The donors were predominantly female (52.5%). 27 donors did not report for follow-up visits. Observation period ranged from 36 to 156 months.
Results: Two patients (5.1%) were hypertensive before donation. One of them continued to had well-controlled hypertension after nephrectomy. Hypertensive angiopathy on ophthalmoscopy was observed in a 57-year old woman six years after donation. Ten patients (25.6%) developed hypertension after nephrectomy. Hypertension was observed in 14.3% (3/21) women and 38% (7/18) men. Cardiovascular disease (silent myocardial infarction) was observed in a 58-year old man. There was no mortality.
Conclusions: The risk of cardiovascular disease does not increase after living
kidney donation. The frequency of hypertension and cardiovascular disease
after living kidney donation is lower than in the general population.
Keywords: Kidney Transplantation, Living Donors
In Press
Original article
Adipose Tissue Can Have a Protective Effect on Outcome After Simultaneous Pancreas–Kidney Transplantation i...Ann Transplant In Press; DOI: 10.12659/AOT.944518
Original article
Preoperative Evidence-Based Practice for Prevention of Early Postoperative Infections in Patients Receiving...Ann Transplant In Press; DOI: 10.12659/AOT.943610
Original article
Prediction of Renal Graft Function 1 Year After Adult Deceased-Donor Kidney Transplantation Using Variables...Ann Transplant In Press; DOI: 10.12659/AOT.944603
Original article
Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.945065
Most Viewed Current Articles
05 Apr 2022 : Original article 12,804
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 9,760
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,192
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,007
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860